About
EyeSense was founded in 2006 as a spin-off of CIBA Vision, a subsidiary of the Novartis Group. Clinical trials with the first prototypes of an eye sensor were successfully conducted as early as 2007. Since 2010, development efforts have been focussed on the development of the FiberSense platform. The first product on this platform is the FiberSense CGM for continuous glucose monitoring. The application for marketing authorisation has already been submitted.
Technologies
Outlook
Mobile Friendly
WordPress.org
Nginx
reCAPTCHA
Remote
Keywords
cgm
enwicklung
biomarker
medizintechnik
medtech
medical device
glucose monitoring
diabetes management
medical equipment manufacturing
fibersense-technologie
kontinuierliche blutzuckermessung
präzise glukoseüberwachung
hormonspiegel
ketone überwachung
software-updates
healthcare technology
fehlerquote
klinische validierung
in-vitro-diagnostik
gesundheitsüberwachung
b2b
langzeit-sensoren
diabetesmanagement
bioreaktoren
optische sensoren
multimodale biomonitoring
sensoren
optischer biosensor
wasserbasierte hydrogele
sensor in hydrogel
Company Information
-
Employees 11
-
Founded 2006
-
Total Funding $8208354
Location
3 Elisabethenstrasse, Basel, Basel-Stadt, Switzerland, 4051
